The complete response rate increased to 12.9% and 16.1 ... therapy is safe with no grade ≥3 toxicities related to efti and KEYTRUDA. IMP761 is a first-in-class agonist LAG-3 antibody designed to ...

NEW HAVEN, Conn., Feb. 11, 2025 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company ...

Adverse events of grade 3 or higher were noted in 26.1% of ... node-negative or not evaluated). Radiation and endocrine therapy were administered according to institutional standards and the ...

Media Release Marking Immutep's transition to a Phase III biotech, the Company's pivotal TACTI-004 trial in first-line non-small cell lung cancer (1L NSCLC) received first regulatory approvalMature da ...

Explore the role of the extracellular matrix (ECM) in prostate cancer progression and discover natural therapies, including milk thistle, turmeric, and green tea, that target the tumor ...

The endocrine system refers to the cells, glands and organs that secrete hormones directly into the blood in order to control physiological and behavioural activities. The effects of the endocrine ...

Datroway's safety profile remains consistent, with 4.2% ILD rate; most cases were low grade. Next: Access Our New, Shockingly Simple 'Alert System ... have received prior endocrine-based therapy ...

Exelixis, Inc. (Nasdaq: EXEL) today announced results from a subgroup analysis of the phase 3 CABINET pivotal study of patients with extra-pancreatic ...

The New Mexico Department of Health Laboratory confirmed a measles case of an unvaccinated teenager in Lea County on ...

BASIC Education Minister Siviwe Gwarube said Grade R practitioners will be formally integrated into the basic education system as educators ... there were currently 12 462 unqualified and ...

Optical measurements through the skin are challenging because they usually represent averages across the various layers of skin that are illuminated. A study in Nature Metabolism uses a depth ...

for 12 months prior to the month of cancer diagnosis from 1 January 2008 (Medicare Part D data are available from 2007) and 31 December 2013 (last capture of cancer cases in SEER). Women with an ...